SCHEMBL6005082

SCHEMBL6005082

O=C(c1ccccc1)c1ccccc1-c1ncc[nH]1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.68
TYRO3 Q06418 1/20 0.68
DYRK1B Q9Y463 1/20 0.68
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MTOR P42345 1/20 0.47
ADK P55263 1/20 0.47
NISCH Q9Y2I1 1/20 0.47
AKR1C3 P42330 1/20 0.44
KMT2A Q03164 3/20 0.44
HCRTR1 O43613 2/20 0.44
HCRTR2 O43614 2/20 0.44
CYP2C8 P10632 1/20 0.42
CYP2C9 P11712 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
MEN1 O00255 1/20 0.41
IDO1 P14902 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10714674 0.90 CSNK1A1 (0.76) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL30965100 0.85 CSNK1A1 (0.73) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL297622 0.85 CSNK1A1 (0.73) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
Hydrochloric Acid SCHEMBL5854599 0.84 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL15478263 0.81 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL11566235 0.81 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL6825869 0.81 CSNK1A1 (1.00) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL10912947 0.80 MAPT (0.55) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
Water SCHEMBL30473073 0.79 CSNK1A1 (0.97) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E
SCHEMBL11985512 0.78 CSNK1A1 (0.68) CSNK1A1TYRO3DYRK1BALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-53149975-A None JP disclosed
EP-1207161-B1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMA CO LTD (JP) 2006-01-18 EP disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
US-6608098-B1 Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-08-19 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed
WO-2001068610-A1 IMIDAZOLYLBENZOPHENONE DERIVATIVES TAISHO PHARMACEUTICAL CO.,LTD (JP) 2001-09-20 WO disclosed
JP-S53149975-A PREPARATION OF IMIDAZOLYLBENZOPHENONES TEIJIN LTD 1978-12-27 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053923-A1 Novel isoindole derivatives GPR119, SLC5A2, SLC5A1 CSNK1A1 258/4885TYRO3 2236/4885DYRK1B 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.